Search research articles
Contact Us
Filters
Showing results (101-110 of 122) with videos related to
Page
of 13
Sort By:
AIDS Patient Care and Stds
|
May 16, 2008
Analyses of HIV-1 drug-resistance profiles among infected adolescents experiencing delayed antiretroviral treatment switch after initial nonsuppressive highly active antiretroviral therapy
Allison Agwu, Jane C Lindsey, Kimberly Ferguson, et al.
Molecular Therapy. Methods & Clinical Development
|
June 2, 2020
Protection against SIV in Rhesus Macaques Using Albumin and CD4-Based Vector-Mediated Gene Transfer
Sergei Spitsin, Bruce C Schnepp, Mary J Connell, et al.
Hepatology (Baltimore, Md.)
|
September 22, 2005
Hepatitis C virus inhibits intracellular interferon alpha expression in human hepatic cell lines
Ting Zhang, Rong-Tuan Lin, Yuan Li, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences
|
March 15, 2013
The glucocorticoid antagonist RU-486 suppresses HIV infectivity and replication
Tami D Benton, Kevin G Lynch, Benoit Dubé, et al.
AIDS (London, England)
|
November 21, 2002
Host genetic profiles predict virological and immunological control of HIV-1 infection in adolescents
Jianming Tang, Craig M Wilson, Shreelatha Meleth, et al.
Psychosomatic Medicine
|
October 16, 2010
Selective serotonin reuptake inhibitor suppression of HIV infectivity and replication
Tami Benton, Kevin Lynch, Benoit Dubé, et al.
Pediatric Research
|
May 9, 2003
Morphine enhances HIV infection of neonatal macrophages
Yuan Li, Jeffrey D Merrill, Kathy Mooney, et al.
Drug and Alcohol Dependence
|
May 10, 2021
Number of opioid overdoses and depression as a predictor of suicidal thoughts
Lily A Brown, Cecile M Denis, Anthony Leon, et al.
Journal of Leukocyte Biology
|
October 14, 2010
Substance P inhibits natural killer cell cytotoxicity through the neurokinin-1 receptor
Linda Monaco-Shawver, Lynnae Schwartz, Florin Tuluc, et al.
AIDS (London, England)
|
April 28, 2015
Reduction of soluble CD163, substance P, programmed death 1 and inflammatory markers: phase 1B trial of aprepitant in HIV-1-infected adults
Pablo Tebas, Sergei Spitsin, Jeffrey S Barrett, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 122) with videos related to
Sort By:
Page
of 13
AIDS Patient Care and Stds
|
May 16, 2008
Analyses of HIV-1 drug-resistance profiles among infected adolescents experiencing delayed antiretroviral treatment switch after initial nonsuppressive highly active antiretroviral therapy
Allison Agwu, Jane C Lindsey, Kimberly Ferguson, et al.
Molecular Therapy. Methods & Clinical Development
|
June 2, 2020
Protection against SIV in Rhesus Macaques Using Albumin and CD4-Based Vector-Mediated Gene Transfer
Sergei Spitsin, Bruce C Schnepp, Mary J Connell, et al.
Hepatology (Baltimore, Md.)
|
September 22, 2005
Hepatitis C virus inhibits intracellular interferon alpha expression in human hepatic cell lines
Ting Zhang, Rong-Tuan Lin, Yuan Li, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences
|
March 15, 2013
The glucocorticoid antagonist RU-486 suppresses HIV infectivity and replication
Tami D Benton, Kevin G Lynch, Benoit Dubé, et al.
AIDS (London, England)
|
November 21, 2002
Host genetic profiles predict virological and immunological control of HIV-1 infection in adolescents
Jianming Tang, Craig M Wilson, Shreelatha Meleth, et al.
Psychosomatic Medicine
|
October 16, 2010
Selective serotonin reuptake inhibitor suppression of HIV infectivity and replication
Tami Benton, Kevin Lynch, Benoit Dubé, et al.
Pediatric Research
|
May 9, 2003
Morphine enhances HIV infection of neonatal macrophages
Yuan Li, Jeffrey D Merrill, Kathy Mooney, et al.
Drug and Alcohol Dependence
|
May 10, 2021
Number of opioid overdoses and depression as a predictor of suicidal thoughts
Lily A Brown, Cecile M Denis, Anthony Leon, et al.
Journal of Leukocyte Biology
|
October 14, 2010
Substance P inhibits natural killer cell cytotoxicity through the neurokinin-1 receptor
Linda Monaco-Shawver, Lynnae Schwartz, Florin Tuluc, et al.
AIDS (London, England)
|
April 28, 2015
Reduction of soluble CD163, substance P, programmed death 1 and inflammatory markers: phase 1B trial of aprepitant in HIV-1-infected adults
Pablo Tebas, Sergei Spitsin, Jeffrey S Barrett, et al.
Page
of 13